Skip to main content
SpringerLink
Log in

Pacemakers (Temporary and Permanent), Implantable Cardioverter Defibrillators (ICDs), and Cardiac Resynchronization Therapy

  • Chapter
  • First Online:
Critical Care of Children with Heart Disease

  • 1508 Accesses

Abstract

Cardiac output is dependent on normal mechanical function of the heart, which in turn is dependent on normal functioning of the cardiac conduction system. When derangements of cardiac conduction occur, this can result in poor cardiac output acutely as well as poor cardiac reserve chronically. These derangements can occur as a result of bradyarrhythmia, tachyarrhythmia, or electrical dyssynchrony (atrioventricular [AV] or interventricular) of the heart.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bernstein AD, Daubert J, Fletcher RD, et al. The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate and multisite pacing. PACE. 2002;25:260–264.

    Article  Google Scholar 

  2. Epstein AE, DiMarco JP, Ellenbogen KA, et al. 2012 ACCF/AHA/HRS Focused Update Incorporated into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61(3):e6–75.

    Article  Google Scholar 

  3. Reddy VY, Knops RE, Sperzel J, et al. Permanent leadless cardiac pacing: results of the LEADLESS trial. Circulation. 2014;129:1466–71.

    Article  Google Scholar 

  4. Knops RE, Tjong FVY, Neuzil P, et al. Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS trial. J Am Coll Cardiol. 2015;65:1497–504.

    Article  Google Scholar 

  5. Reddy VY, Exner DV, Cantillon DJ, et al. Percutaenous implantation of an entirely intracardiac leadless pacemaker. N Eng J Med. 2015;373:1125–35.

    Article  CAS  Google Scholar 

  6. Ritter P, Duray GZ, Steinwender C, et al. Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study. Eur Heart J. 2015;36(37):2510–19

    Article  Google Scholar 

  7. DiMarco JP. Implantable cardioverter-defibrillators. N Engl J Med. 2003;34:1836–1847.

    Article  Google Scholar 

  8. Schneider AE, Burkhart HM, Ackerman MJ, et al. Minimally invasive epicardial implantable cardioverter-defibrillator placement for infants and children: an effective alternative to the transvenous approach. Heart Rhythm. 2016;13:1905–12.

    Article  Google Scholar 

  9. Bardy GH, Smith WM, Hood MA, et al. An entirely subcutaneous implantable cardioverter-deibrillator. N Engl J Med. 2010;363(1):36–44.

    Article  CAS  Google Scholar 

  10. Stephenson EA, Batra AS, Knilans TK, et al. A multicenter experience with novel implantable cardioverter-defibrillator configurations in pediatric and congenital heart disease. J Cardiovasc Electrophysiol. 2006;17:41–46.

    Article  Google Scholar 

  11. Burke MC, Gold MR, Knight BP, et al. Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry. J Am Coll Cardiol. 2015;65(16):1605–1615.

    Article  Google Scholar 

  12. Silka MJ, Hardy MG, Menashe VD, et al. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol. 1998;32:245–251.

    Article  CAS  Google Scholar 

  13. Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356:975–981.

    Article  CAS  Google Scholar 

  14. Khairy P, Landzberg MJ, Gatzoulis MA, et al. Value of programmed ventricular stimulation after tetralogy of Fallot repair. Circulation. 2004;109:1994–2000.

    Article  Google Scholar 

  15. Bristow MR, Saxon LA, Boehmer J et al. Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–2150.

    Article  CAS  Google Scholar 

  16. Auricchio A, Stellbrink C, Sack S et al. Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol. 2002;39:2026–2033.

    Article  Google Scholar 

  17. Abraham WT, Fisher WG, Smith AL et al. MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845–1853.

    Article  Google Scholar 

  18. Cazeau S, Leclercq C, Lavergne T et al. Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873–880.

    Article  CAS  Google Scholar 

  19. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;35:225–237.

    Article  Google Scholar 

  20. Cecchin F, Frangini PA, Brown DW, et al. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. J Cardiovasc Electrophysiol. 2009;20:58–65.

    Article  Google Scholar 

  21. Dubin AM, Janousek J, Rhee E, et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol. 2005;46:2277–2283.

    Article  Google Scholar 

  22. Janousek J, Gebauer RA, Abdul-Khaliq H, et al. Cardiac resynchronization therapy in pediatric and congenital heart disease: differential effects in various anatomical and functional substrates. Heart. 2009;95:1165–71

    Article  CAS  Google Scholar 

  23. Zimmerman FJ, Starr JP, Koenig PR, et al. Acute hemodynamic benefit of multisite ventricular pacing after congenital heart surgery. Ann Thorac Surg. 2003;75:1775–80.

    Article  Google Scholar 

  24. Bacha EA, Zimmerman FJ, Mor-Avi V, et al. Ventricular resynchronization by multisite pacing improves myocardial pacing in the postoperative single-ventricle patient. Ann Thorac Surg. 2004;78:1678–83.

    Article  Google Scholar 

  25. Khairy P, Van Hare GF, Balaji S, et al. PACES/HRS Expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease. Can J Cardiol. 2014;30:e1–63.

    Article  Google Scholar 

  26. Slotwiner D, Varma N, Akar JG, et al. HRS expert consensus statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Heart Rhythm. 2015;12:e69–100.

    Article  Google Scholar 

  27. Kozik TM, Chien G, Connolly TF, et al. iPad2 use in patients with implantable cardioverter defibrillators causes electromagnetic interference: the EMIT study. J Am Heart Assoc. 2014;3:e000746.

    Article  Google Scholar 

  28. Lee S, Fu K, Kohno T, et al. Clinically significant magnetic interference of implanted cardiac devices by portable headphones. Heart Rhythm. 2009;6:1432–36.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Cardiology, Children’s Hospital of UPMC, Pittsburgh, PA, USA

    Christopher W. Follansbee, Lee Beerman & Gaurav Arora

  2. University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    Christopher W. Follansbee, Lee Beerman & Gaurav Arora

Authors
  1. Christopher W. Follansbee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lee Beerman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gaurav Arora
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gaurav Arora .

Editor information

Editors and Affiliations

  1. Chief, Division of Cardiac Critical Care Medicine Executive Director, Telemedicine Co-director, Children’s National Heart Institute, Professor of Pediatrics, George Washington University School of Medicine, Children’s National Health System, Washington, DC, USA

    Ricardo A. Munoz

  2. Department of Pediatric Cardiothoracic Surgery, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA

    Victor O. Morell

  3. Associate Medical Director, CHCO Heart Institute Head, Pediatric Cardiac Critical Care Program & Inpatient Services Director, Cardiac Intensive Care Unit Children’s Hospital Colorado, Tenured Professor of Pediatrics, Pediatric Cardiology and Intensive Care University of Colorado Denver, School of Medicine, Aurora, CO, USA

    Eduardo M. da Cruz

  4. Department of Pharmacy, Pediatric Critical Care, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA

    Carol G. Vetterly

  5. Department of Pediatric Cardiothoracic Surgery, UPMC – Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA

    Jose Pedro da Silva

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Follansbee, C.W., Beerman, L., Arora, G. (2020). Pacemakers (Temporary and Permanent), Implantable Cardioverter Defibrillators (ICDs), and Cardiac Resynchronization Therapy. In: Munoz, R., Morell, V., da Cruz, E., Vetterly, C., da Silva, J. (eds) Critical Care of Children with Heart Disease . Springer, Cham. https://doi.org/10.1007/978-3-030-21870-6_52

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-21870-6_52

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-21869-0

  • Online ISBN: 978-3-030-21870-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation